Corcept Therapeutics Incorporated (CORT) Social Stream



Corcept Therapeutics Incorporated (CORT): $23.26

0.32 (+1.39%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CORT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

CORCEPT THERAPEUTICS INC (CORT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CORCEPT THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 4 $35 $16 $24.75 $23.38 5.86%
2022-01-26 4 $35 $16 $25.5 $23.38 9.07%
2022-01-28 5 $35 $16 $26.4 $23.38 12.92%
2022-02-02 6 $35 $16 $27 $23.38 15.48%
2022-04-19 6 $35 $16 $27.166 $23.38 16.19%
2022-05-06 6 $35 $16 $26.833 $23.38 14.77%
2022-07-13 6 $35 $16 $28.8 $23.38 23.18%
2022-07-27 6 $35 $16 $29.833 $23.38 27.6%
2022-08-01 6 $35 $16 $29.833 $23.38 27.6%
2022-08-04 6 $45 $16 $32.166 $23.38 37.58%
2022-11-07 6 $45 $18 $32.5 $23.38 39.01%
2022-12-02 6 $45 $18 $32.166 $23.38 37.58%
2022-12-09 6 $45 $18 $31.666 $23.38 35.44%
2022-12-20 6 $44 $18 $31.5 $23.38 34.73%

The Trend in the Analyst Price Target


CORT's average price target has moved up $4.33 over the prior 38 weeks.

Over the past 47 weeks, CORT's average upside potential has been 27.19%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-06 6 35 16 26.833 19.20 39.76%
2022-08-01 6 35 16 29.833 27.33 9.16%
2022-08-13 6 45 18 32.500 28.41 14.4%
2022-11-07 6 45 18 32.500 24.84 30.84%
2022-12-20 6 44 18 31.500 20.52 53.51%

CORT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.83 4 0 1 0 0 6

The Trend in the Broker Recommendations


Over the past 122 days, CORT's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, CORCEPT THERAPEUTICS INC's variance in analysts' estimates is lower than -915.26% of them.
  • In terms of how CORCEPT THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 377.76% of that group.
  • CORT has a higher upside potential (average analyst target price relative to current price) than 254.84% of Pharmaceutical Products stocks.
  • In the context of stocks in the mid market cap category, CORCEPT THERAPEUTICS INC's average analyst price target is higher than 509.06% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CORCEPT THERAPEUTICS INC are INVA, ACAD, and PTCT.

What is the outlook for CORT? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6846 seconds.